Babies born missing all or part of a limb have what doctors call limb reduction defects, and these occur in roughly 4 to 5 out of every 10,000 births. There is no single cause. The underlying reasons range from inherited gene mutations and chromosomal abnormalities to disrupted blood supply in the womb, physical entanglement with amniotic tissue, maternal health conditions, and environmental exposures. In many individual cases, no definitive cause is ever found, which makes limb differences one of the more frustrating puzzles in birth defect research.
How a Limb Normally Forms
Understanding why limbs sometimes fail to develop starts with how they normally take shape. Around the fourth week of pregnancy, small buds of tissue push outward from the embryo’s torso. Each bud is capped by a thin ridge of cells that sends chemical signals deep into the growing tissue, directing it to elongate, branch, and eventually form fingers or toes. This ridge acts as the command center: if it is damaged or its signals are interrupted, the limb truncates at whatever stage it had reached.
Growth factor proteins are central to this signaling. Research in chick embryos showed that when the ridge is surgically removed, the underlying tissue quickly dies off and limb development stops. But when a specific growth factor protein was supplied to the tissue after the ridge was removed, relatively normal limb development continued.
The process is tightly choreographed across multiple axes: the limb has to know which end is the shoulder and which is the hand, which side faces forward and which faces backward, and which edge becomes the thumb versus the pinky. Disruption to any of these signaling pathways, whether by a faulty gene, a toxic exposure, or a physical interruption of blood flow, can derail limb formation at various stages and produce a wide spectrum of outcomes, from a missing finger to an entirely absent arm.
How Common Are Limb Reduction Defects
A large population-based study using Norway’s medical birth registry from 1970 to 2016 found an overall prevalence of 4.4 per 10,000 births, with upper limb defects outnumbering lower limb ones.1PLOS ONE. Epidemiology of limb reduction defects as registered in the Medical Birth Registry of Norway, 1970-2016: Population based study The rate stayed relatively stable over decades, which tells us this isn’t a problem that’s simply getting worse or better with modern medicine. What has changed is our ability to identify causes: a Dutch population study showed that when more than one limb is affected, the chance of pinpointing a genetic explanation rises dramatically.2PubMed Central. Etiological diagnosis in limb reduction defects and the number of affected limbs: A population‐based study in the Northern Netherlands When only one limb is involved, as is more common, the cause often remains unknown.
Genetic Causes
A substantial share of limb differences trace to something written in the baby’s DNA. In one clinical series, fetal causes accounted for over half of all congenital limb anomalies, with single-gene disorders making up the largest share and chromosomal abnormalities like trisomy 13, trisomy 18, and certain deletions accounting for a smaller but significant fraction.3PubMed Central. A morpho-etiological description of congenital limb anomalies
Several well-characterized genetic syndromes involve limb differences. Mutations in the TBX5 gene cause Holt-Oram syndrome, which affects the hands and arms alongside heart defects. Fanconi anemia, caused by mutations in the FANCA gene and others, can produce absent or malformed thumbs. Apert syndrome, linked to the FGFR2 gene, fuses fingers together. And mutations in TP63 produce a condition where the central rays of the hands and feet fail to form, resulting in a cleft or “lobster claw” appearance.4The Journal of Hand Surgery. Genetic Syndromes Associated With Congenital Upper Limb Differences
HOX genes, which help the embryo lay out its body plan, are another important group. Mutations in HOXD13 and HOXA13 were among the first limb malformations linked to specific human genes, causing conditions like synpolydactyly (fused and extra fingers) and hand-foot-genital syndrome.5PubMed. Limb malformations and the human HOX genes Different types of mutations within the same gene can produce surprisingly different limb abnormalities, which partly explains why two families carrying mutations in the same gene can have children with very different physical outcomes.
Not all genetic causes are inherited from parents. Some arise as fresh, spontaneous mutations in the embryo itself. Somatic mosaic mutations, meaning changes that occur after fertilization and affect only some cells, have been linked to overgrowth syndromes where a limb grows too large rather than too small.4The Journal of Hand Surgery. Genetic Syndromes Associated With Congenital Upper Limb Differences
Thalidomide and Drug-Related Causes
The thalidomide disaster of the late 1950s and early 1960s remains the most notorious example of a medication causing limb defects. Prescribed as a sedative and anti-nausea drug for pregnant women, it caused severe limb shortening or absence in thousands of babies worldwide. Researchers now understand the molecular mechanism behind this: thalidomide triggers the destruction of a protein called SALL4, which is critical for limb development. Mutations in the human gene encoding SALL4 produce limb abnormalities that closely resemble thalidomide-caused defects, which effectively confirmed that SALL4 degradation is the link.6Nature Chemical Biology. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
An interesting wrinkle: thalidomide causes birth defects in rabbits and humans but not in mice, even when mice are genetically engineered to carry the human version of the protein that thalidomide binds to. The difference comes down to small variations in the SALL4 protein’s sequence between species, meaning the drug can grab and destroy it in some animals but not others.6Nature Chemical Biology. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate This species difference is a sobering reminder of why animal testing sometimes misses dangers that appear in human pregnancies.
Thalidomide is still used today for certain cancers and inflammatory conditions, but under extremely strict prescribing programs that require pregnancy prevention measures. Other medications, including certain anti-seizure drugs and high doses of vitamin A derivatives, are also known to carry limb defect risks during pregnancy, though none as dramatically as thalidomide.
Maternal Health and Diabetes
A mother’s health before and during early pregnancy can influence limb formation. Pregestational diabetes stands out as one of the strongest non-genetic risk factors. One population-based study found that mothers with diabetes before pregnancy had roughly 12 times the odds of having a baby with a limb deficiency compared to mothers without diabetes.7PubMed. Maternal risk factors for congenital limb deficiencies: A population-based case-control study A separate large study found that type 2 diabetes carried a stronger association with birth defects than type 1, and that the overall malformation rate was nearly twice as high in diabetic pregnancies as in non-diabetic ones.8PubMed. Risk of birth defects associated with maternal pregestational diabetes
The mechanism likely involves elevated blood sugar during the critical early weeks when organs and limbs are forming. High glucose levels can disrupt the signaling pathways that guide cell growth and tissue patterning. Because limb buds appear so early in pregnancy, often before a woman even knows she is pregnant, the window of vulnerability is brief but important. This is one reason why doctors emphasize blood sugar control before conception for women with diabetes who are planning pregnancies.
Amniotic Band Syndrome
Not all limb defects originate from inside the embryo. In amniotic band syndrome, strands of tissue from the ruptured inner lining of the amniotic sac wrap around developing limbs, fingers, or toes. If the bands constrict tightly enough, they can cut off blood flow and effectively amputate parts of a limb in the womb. A case report documented a baby born with amputation of the right upper arm after an amniotic band encircled and constricted the limb, with the pregnancy complicated by an abnormally shaped uterus that may have increased pressure and promoted the rupture.9PubMed Central. Amniotic constriction band syndrome resulting in amputation caused by septate uterus: a case report
There is actually a long-running debate about how this works. The traditional explanation focuses on the fibrous bands themselves as the culprit. But a critical review of the clinical and experimental literature argued that the bands may be a late, secondary event and that the real pathogenic driver is vascular disruption and hemorrhage.10American Journal of Obstetrics and Gynecology. Amniotic band syndrome: Reevaluation of its pathogenesis This distinction matters for more than academic reasons: if the primary problem is vascular rather than mechanical, then the visible bands found at birth may sometimes be misleading, and the true cause of the limb loss is an interruption of blood supply.
Vascular Disruption
Beyond amniotic bands, blood supply problems on their own can cause limb defects. The vascular disruption hypothesis holds that events like abnormal blood vessel development, reduced blood flow from the placenta, or exposure to substances that constrict blood vessels can starve a developing limb of oxygen and nutrients, leading to tissue death and limb loss. One review of cases attributed to vascular disruption found that limb amputations tended to occur at specific anatomical levels, particularly the forearm, wrist, and finger joints, often with small tissue remnants (“nubbins”) at the stump that suggest an interrupted growth process rather than a genetic blueprint error.11PubMed. Malformations attributed to the process of vascular disruption
A review examining the evidence for vascular pathogenesis noted that transverse limb defects, where the limb appears cleanly truncated across its width, sometimes result from placental vascular abnormalities, low blood flow, abnormal vessel development, uterine compression, or blood disorders in the mother.12PubMed. Examining the evidence for vascular pathogenesis of selected birth defects This category of cause is particularly relevant for isolated, one-sided limb defects with no other abnormalities, which are the type most often left without a clear diagnosis.
Environmental Exposures and Pesticides
The role of environmental chemicals is harder to pin down than genetics or vascular events, but the suspicion has been around for decades. A study of parental occupational exposure to pesticides found weak but consistent elevated risks of limb reduction defects, particularly when the baby had additional abnormalities beyond the limb defect.13PubMed. Potential parental exposure to pesticides and limb reduction defects
More recently, research in California’s agricultural San Joaquin Valley looked at residential proximity to specific pesticide applications and found associations between transverse limb deficiencies and several chemical groups, including petroleum derivatives, triazines, and certain copper-containing compounds.14PubMed. Residential agricultural pesticide exposures and risks of selected birth defects among offspring in the San Joaquin Valley of California These are observational associations, not proof of direct causation, and the number of affected cases was small. But the findings are consistent enough across studies to keep environmental exposures on the list of plausible contributing factors, particularly for families living in heavily agricultural regions.
Risks From Prenatal Procedures
An unexpected and unsettling source of limb defects surfaced in the 1990s when researchers noticed that chorionic villus sampling, a procedure where a small piece of placental tissue is removed for genetic testing, appeared to cause limb abnormalities in some cases. The risk was strongly linked to timing: the earlier in pregnancy the procedure was performed, the more severe the limb defects tended to be.15The Lancet. Analysis of limb reduction defects in babies exposed to chorionic villus sampling This pattern held for both isolated limb defects and cases involving additional abnormalities of the jaw and mouth.16PubMed. Limb defects after chorionic villus sampling
The suspected mechanism involves vascular disruption: the procedure may damage tiny blood vessels in or near the placenta, reducing blood flow to developing limbs during the critical formation period. As a result, guidelines now recommend performing chorionic villus sampling no earlier than 10 weeks of gestation, and the procedure is far less common today than it once was, partly because non-invasive blood tests can now screen for many chromosomal conditions.
Even fetoscopic laser surgery for twin-to-twin transfusion syndrome, a life-saving procedure for certain complicated twin pregnancies, carries a small risk. One large case series found that about 2% of pregnancies treated with fetoscopic laser developed amniotic band disruption afterward, most commonly affecting the lower extremities, with toe amputations occurring in a third of those cases.17American Journal of Obstetrics and Gynecology. Prevalence, risk factors, and outcome of postprocedural amniotic band disruption sequence after fetoscopic laser surgery in twin-twin transfusion syndrome
Can Limb Defects Be Detected Before Birth
Prenatal ultrasound can pick up many limb abnormalities, but its sensitivity varies considerably depending on the type of defect. A 20-year single-center study found that ultrasound detected about 76% of limb reduction defects involving the long bones, and about 81% of limb defects classified as arthrogryposis, where joints are locked in fixed positions.18PubMed Central. The utility of ultrasound for the detection of fetal limb abnormalities – a 20-year single-center experience Smaller defects affecting individual fingers or toes were far harder to spot, with detection rates dropping below 20%.
When limb problems are found on ultrasound, and amniotic bands are visible, fetoscopic surgery to release the bands before they cause permanent damage has become a real, if still experimental, option. A systematic review of 37 cases found that fetoscopic band release preserved limb function in about three-quarters of cases, with fetal survival reaching roughly 89%.19PubMed. Fetoscopic Release of Amniotic Bands Based on the Evidence-A Systematic Review The tradeoff is significant: over half of the pregnancies experienced premature rupture of membranes after the procedure, and preterm delivery is a serious complication. Still, when the alternative is loss of a limb or fetal death from cord constriction, the calculus can favor intervention.
The Role of Stress and Epigenetics
Animal research has raised the possibility that maternal stress during pregnancy could influence limb development through epigenetic changes, meaning shifts in gene activity that don’t alter the DNA sequence itself. In mice, maternal stress retarded limb bud formation and the regression of webbing between developing digits by about half a day, and roughly a tenth of detectable gene transcripts in the developing limbs were significantly altered, including genes known to be involved in limb growth. The question of whether similar effects occur in human pregnancies at levels of everyday stress remains unanswered, and researchers are careful to distinguish the controlled extreme stress used in animal models from the stress a pregnant person experiences in daily life.
Early Prosthetic Fitting for Children
For children born with limb differences, the timing of their first prosthesis matters. A systematic review found that children fitted with a prosthesis before age two were significantly less likely to reject it later in life compared to those fitted after age two, with the odds of rejection roughly tripling in the later group.20PubMed. Prescription of the first prosthesis and later use in children with congenital unilateral upper limb deficiency: A systematic review The logic is intuitive: a young child who grows up with a prosthesis as part of their body image integrates it more naturally than one who has already developed compensatory movement patterns without one.
That said, many individuals with congenital limb differences choose not to use a prosthesis at all and develop remarkable functional adaptations. The decision is deeply personal, and the evidence on whether early fitting improves long-term function (as opposed to just acceptance of the device) remains thin.
Psychosocial Experience of Limb Difference
The physical aspects of limb difference are only part of the picture. Research into how young people with limb differences experience their condition consistently points to the social environment as a major factor in psychological well-being. A scoping review found that the social environment directly shaped the development of self-concept and psychological health in children with limb differences.21International Journal of Orthopaedic and Trauma Nursing. Self-concept development in children with limb differences: A scoping review A qualitative study of young people with limb difference found that interactions with peers who also had limb differences had a positive impact, while uninvited comments and assumptions from others were harmful.22PubMed. Young people’s experience of limb difference and how this impacts their relationships with others
These findings have shifted clinical thinking away from a purely surgical or prosthetic focus and toward a more holistic approach that includes peer support, psychological services, and family education. Organizations that connect children with limb differences to one another have become a meaningful part of care, not just a nice add-on.
What Limbless Animals Reveal About the Genetics
An unexpected window into human limb development comes from studying animals that have lost their limbs over evolutionary time. Snakes and caecilians (limbless amphibians that look like large worms) didn’t just lose their limbs physically; they lost or degraded some of the genes and regulatory DNA elements that drive limb formation. Researchers found that snakes are missing a gene called Tulp3, which is involved in the signaling pathway that establishes front-to-back patterning in limb buds, while caecilians are missing Grem1, a gene whose protein forms a feedback loop critical for limb outgrowth.23Molecular Biology and Evolution. Convergent Degenerated Regulatory Elements Associated with Limb Loss in Limbless Amphibians and Reptiles In mice, losing Tulp3 is lethal and produces abnormal limb patterning, underscoring how essential these genes are when limbs are supposed to form.
The fact that two completely unrelated lineages, snakes and caecilians, independently lost different genes in the same developmental pathway suggests that this pathway has multiple vulnerable points. For human medicine, these studies help map which genes and regulatory elements are most critical, potentially guiding future genetic screening or even regenerative research. The basic genetic toolkit for building a limb is deeply conserved across vertebrates, and understanding where it breaks in nature illuminates where it might break in human development.
Why Humans Cannot Regrow Limbs
A question that often follows “why are babies born without limbs” is “why can’t we just regrow them?” Salamanders can regenerate entire limbs throughout their lives, so the genetic instructions for building a limb clearly exist in vertebrate biology. Research into this gap suggests that the key difference lies not in the genes themselves but in a specific cell behavior: the ability of connective tissue cells to revert to an earlier, more flexible state and form a mass of growth cells called a blastema. Salamander cells do this readily; mammalian cells do not. Since every human developed limbs as an embryo, the genetic program for making a limb exists in every cell of the body. The barrier is triggering that program again in adult tissue, and specifically, getting mature connective tissue cells to behave like embryonic ones. Cracking that problem remains one of the grand challenges of regenerative medicine.